BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38529392)

  • 21. Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology-Head and Neck Surgery: State of the Art Review.
    Cramer JD; Shuman AG; Brenner MJ
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):627-636. PubMed ID: 29484922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH.
    Roberts LN; Hernandez-Gea V; Magnusson M; Stanworth S; Thachil J; Tripodi A; Lisman T
    J Thromb Haemost; 2022 Oct; 20(10):2237-2245. PubMed ID: 35948998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercoagulability in Cushing's syndrome: From arterial to venous disease.
    St-Jean M; Lim DST; Langlois F
    Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101496. PubMed ID: 33795197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.
    Cherenko M; Appelman-Dijkstra NM; Priego Zurita AL; Biermasz NR; Dekkers OM; Klok FA; Reisch N; Aulinas A; Biagetti B; Cannavo S; Canu L; Detomas M; Devuyst F; Falhammar H; Feelders RA; Ferrau F; Gatto F; Grasselli C; van Houten P; Hoybye C; Isidori AM; Kyrilli A; Loli P; Maiter D; Nowak E; Pivonello R; Ragnarsson O; Steenaard RV; Unger N; van de Ven A; Webb SM; Yeste D; Ahmed SF; Pereira AM
    Endocr Connect; 2024 Jun; 13(6):. PubMed ID: 38614126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
    Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
    Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombophilia, risk factors and prevention.
    Campello E; Spiezia L; Adamo A; Simioni P
    Expert Rev Hematol; 2019 Mar; 12(3):147-158. PubMed ID: 30773075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.
    Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Dapena JL; Rives S; Sevilla J; Menárguez López Á; Panesso Romero M; Montoya C; Vagace JM; Molina Hurtado JR; García-Morín M; García Abós M; Mendoza Sánchez MC; Lendínez F; Palomo Moraleda P; Tallón M; González B; Urrutia E; Serna JV; Peláez Pleguezuelos I; Martínez Merino M; Ramos Elbal E; Orellana E; Benítez Muñoz H; Berrueco R
    J Thromb Haemost; 2022 Jun; 20(6):1390-1399. PubMed ID: 35289066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
    Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
    J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial thrombosis as primary presentation of endogenous Cushing's syndrome.
    Alexander V; Koshy M; Dasgupta R; Carey RA
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30733248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism occurring during adolescence.
    Biss T; Alikhan R; Payne J; Alamelu J; Williams M; Richards M; Mathias M; Tunstall O; Chalmers E
    Arch Dis Child; 2016 May; 101(5):427-32. PubMed ID: 26787610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
    Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
    Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
    Spyropoulos AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic Venous Thromboembolism and Major Bleeding After Renal Transplantation: Should We Use Pharmacologic Thromboprophylaxis?
    Musso D; Robaina GI; Figueroa Córdoba AV; Martini GD; Albertini RA; Chiurchiu C; Tabares AH
    Transplant Proc; 2016 Oct; 48(8):2773-2778. PubMed ID: 27788816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.
    Koraćević G; Stojanović M; Petrović S; Simić D; Sakač D; Vlajković M; Stevic M; Kocić M; Đorđević M; Koraćević M
    Acta Endocrinol (Buchar); 2020; 16(2):123-128. PubMed ID: 33029226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.